Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

11 mars 2010 09h23 HE | Source: Mateon Therapeutics

OXiGENE Announces $7.5 Million Financing

SOUTH SAN FRANCISCO, Calif., March 11, 2010 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN) (Stockholm:OXGN), a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer...
25 févr. 2010 16h00 HE | Source: Mateon Therapeutics

OXiGENE Reports Fourth Quarter and Year-End 2009 Results

SOUTH SAN FRANCISCO, Calif., Feb. 25, 2010 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN) (Stockholm:OXGN), a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer...
19 févr. 2010 16h00 HE | Source: Mateon Therapeutics

OXiGENE Announces Fourth Quarter and Fiscal 2009 Earnings Conference Call and Webcast

SOUTH SAN FRANCISCO, Calif., Feb. 19, 2010 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN) (Stockholm:OXGN), a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer...
11 févr. 2010 10h20 HE | Source: Mateon Therapeutics

OXiGENE Announces Restructuring to Focus Resources on Key Programs and Provides Business Update

SOUTH SAN FRANCISCO, Calif., Feb. 11, 2010 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN) (Stockholm:OXGN), a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer...
04 févr. 2010 09h00 HE | Source: Mateon Therapeutics

OXiGENE Announces Results of Stockholder Vote on Proposed Merger With VaxGen

SOUTH SAN FRANCISCO, Calif., Feb. 4, 2010 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN) (Stockholm:OXGN), a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer...
07 déc. 2009 09h49 HE | Source: Mateon Therapeutics

OXiGENE Reports Promising Preclinical Data Using OXi4503 in Acute Myelogenous Leukemia Models at ASH Conference

SOUTH SAN FRANCISCO, Calif., Dec. 7, 2009 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN) (Stockholm:OXGN), a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer...
17 nov. 2009 12h30 HE | Source: Mateon Therapeutics

OXiGENE Reports Positive Safety Data From Phase 2 Trial of ZYBRESTAT in Non-Small Cell Lung Cancer at the 2009 AACR-NCI-EORTC Conference

SOUTH SAN FRANCISCO, Calif., Nov. 17, 2009 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN) (Stockholm:OXGN), a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer...
12 nov. 2009 16h00 HE | Source: Mateon Therapeutics

OXiGENE to Present at American Society of Hematology and AACR/NCI/EORTC Meetings

SOUTH SAN FRANCISCO, Calif., Nov. 12, 2009 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN) (Stockholm:OXGN), a clinical stage, biopharmaceutical company developing novel therapeutics to treat cancer...
10 nov. 2009 02h00 HE | Source: Mateon Therapeutics

OXiGENE to Present at Merriman Curhan Ford and Lazard Healthcare Conferences

SOUTH SAN FRANCISCO, Calif., Nov. 10, 2009 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN) (Stockholm:OXGN), a clinical stage, biopharmaceutical company developing novel therapeutics to treat cancer...
09 nov. 2009 02h00 HE | Source: Mateon Therapeutics

OXiGENE Reports Third Quarter 2009 Financial Results

SOUTH SAN FRANCISCO, Calif., Nov. 9, 2009 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN) (Stockholm:OXGN), a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer...

Page précédente

Page suivante